Quantcast
Last updated on April 17, 2014 at 15:37 EDT

Latest Estrogen Stories

2012-04-02 15:31:10

At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of cancer often respond favorably to treatments called aromatase inhibitors, like tamoxifen, which cause cell death by preventing estrogen from reaching the cancerous cells. Over time, however, the disease often becomes resistant to estrogen deprivation from the drugs–making...

92030686
2012-03-29 12:05:24

A new review of existing research reveals having one alcoholic beverage day could boost a woman´s risk of breast cancer by 5%. Researchers from Germany, France, and Italy also discovered having 3 or more drinks a day could increase the risk of breast cancer by 50%. “Alcohol consumption is causally related with breast cancer,” the study authors concluded after reviewing 113 prior studies. They attributed 2 percent of breast cancer cases in Europe and North America to...

2012-03-28 23:02:53

Dry Eye Syndrome Is High among Menopausal Women and the Reason May Surprise You, Reports Bio-Logic Aqua Research Founder Sharon Kleyne. Grants Pass, OR (PRWEB) March 28, 2012 Dry eye has become the number one complaint heard by eye doctors in the United States. In a recent interview, eye moisture expert Sharon Kleyne, founder of Bio-Logic Aqua Research, Inc. and host of the Sharon Kleyne Hour Power of Water radio talk show, noted that the incidence of dry eye increases as we age and that...

2012-03-28 06:26:17

EMERYVILLE, Calif., March 28, 2012 /PRNewswire/ -- Bionovo, Inc. (OTCQB: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that the Company's independent Data Safety Monitoring Board (DSMB) recommended that the Phase 3 trial of Menerba (MF101) could continue as designed after an initial review of its clinical safety and tolerability data. Menerba is Bionovo's oral botanical drug candidate...

2012-03-24 03:41:35

Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chances of cancer spreading (metastasising) in the bone. Professor Michael Gnant told the eighth European Breast Cancer Conference (EBCC-8) today (Friday) that the latest results from the BOLERO-2 trial would change clinical practice. "These results...

2012-03-24 03:35:37

Study presented Friday at 65th annual meeting of Society of Surgical Oncology Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC)....

2012-03-20 16:48:08

Researchers at the University of Cincinnati have found evidence that, in addition to affecting the heart, brain and nervous system, bisphenol A (BPA), could affect a mammal´s ability to reproduce by altering the structure of the uterus in ways that can progress to a potentially fatal infection. Infection and inflammation of the uterus, or pyometra, is most commonly seen in animals like dogs and cats but can also affect humans. It is a result of hormonal and structural changes in the...

2012-03-19 23:01:02

Stay Young & Sexy with Bio-Identical Hormone Replacement: The Science Explained, the groundbreaking book on BHRT, is newly updated, including foreword by Suzanne Somers. Petaluma, CA (PRWEB) March 19, 2012 Smart Publications announces the updated and expanded version of Stay Young & Sexy with Bio-Identical Hormone Replacement: The Science Explained, the groundbreaking book on the benefits of bio-identical hormone replacement therapy (BHRT) by pioneering medical advocates of BHRT,...

Estrogen-Only Therapy Reduces Breast Cancer Chances In Post-Menopausal Women
2012-03-07 11:25:01

A new study published this week shows that women who used estrogen alone as hormone replacement therapy after menopause had a lower risk of developing breast cancer up to five years after they stopped taking it, reports Shari Roan for the Los Angeles Times. This discovery adds yet another twist to the ongoing story on hormone replacement therapy for treatment of hot flashes and poor sleep quality. The estrogen-only therapy appears to cut the risk of having breast cancer by about 20...

2012-02-28 08:00:00

A new testosterone boosting and muscle retention product from the product line “Cell Formula” is now available by True Healthy Products for Pre-release with limited quantities. (PRWEB) February 28, 2012 True Healthy Products is offering a new product line for Pre-Release first come, first serve sales. The company´s new product line called “Cell Formula” includes four products. The Cell Formula product, the “Daily Optimizer” is attracting quite a bit...